These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21804067)

  • 41. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity.
    Guyard-Dangremont V; Lagrost L; Gambert P
    J Lipid Res; 1994 Jun; 35(6):982-92. PubMed ID: 8077854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
    Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Hough G; Wagner A; Nakamura K; Garber DW; Datta G; Segrest JP; Hama S; Fogelman AM
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1100-4. PubMed ID: 14582455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1.
    He D; Zhao M; Wu C; Zhang W; Niu C; Yu B; Jin J; Ji L; Willard B; Mathew AV; Chen YE; Pennathur S; Yin H; He Y; Pan B; Zheng L
    Redox Biol; 2018 May; 15():228-242. PubMed ID: 29277016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
    Sharifov OF; Xu X; Gaggar A; Tabengwa EM; White CR; Palgunachari MN; Anantharamaiah GM; Gupta H
    Inflammation; 2014 Oct; 37(5):1401-12. PubMed ID: 24647607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes.
    Morgantini C; Natali A; Boldrini B; Imaizumi S; Navab M; Fogelman AM; Ferrannini E; Reddy ST
    Diabetes; 2011 Oct; 60(10):2617-23. PubMed ID: 21852676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.
    Van Lenten BJ; Wagner AC; Navab M; Anantharamaiah GM; Hui EK; Nayak DP; Fogelman AM
    Circulation; 2004 Nov; 110(20):3252-8. PubMed ID: 15533864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D-4F, an apolipoprotein A-I mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1.
    Xie Q; Zhao SP; Li F
    Tohoku J Exp Med; 2010 Mar; 220(3):223-8. PubMed ID: 20208418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and function of HDL mimetics.
    Navab M; Shechter I; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):164-8. PubMed ID: 19608977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.
    D'Souza W; Stonik JA; Murphy A; Demosky SJ; Sethi AA; Moore XL; Chin-Dusting J; Remaley AT; Sviridov D
    Circ Res; 2010 Jul; 107(2):217-27. PubMed ID: 20508181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cationic peptides neutralize Ox-LDL, prevent its uptake by macrophages, and attenuate inflammatory response.
    Aluganti Narasimhulu C; Selvarajan K; Brown M; Parthasarathy S
    Atherosclerosis; 2014 Sep; 236(1):133-41. PubMed ID: 25036240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of multianalyte microphysiometry to characterize macrophage metabolic responses to oxidized LDL and effects of an apoA-1 mimetic.
    Kimmel DW; Dole WP; Cliffel DE
    Biochem Biophys Res Commun; 2013 Feb; 431(2):181-5. PubMed ID: 23313489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins.
    Liang HQ; Rye KA; Barter PJ
    J Lipid Res; 1994 Jul; 35(7):1187-99. PubMed ID: 7964180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apolipoprotein A-I mimetic peptides.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Yu N; Ansell BJ; Datta G; Garber DW; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1325-31. PubMed ID: 15831812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apolipoprotein A-I mimetic peptides.
    Van Lenten BJ; Wagner AC; Anantharamaiah GM; Navab M; Reddy ST; Buga GM; Fogelman AM
    Curr Atheroscler Rep; 2009 Jan; 11(1):52-7. PubMed ID: 19080728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells.
    Ou Z; Ou J; Ackerman AW; Oldham KT; Pritchard KA
    Circulation; 2003 Mar; 107(11):1520-4. PubMed ID: 12654610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.
    Navab M; Hama SY; Cooke CJ; Anantharamaiah GM; Chaddha M; Jin L; Subbanagounder G; Faull KF; Reddy ST; Miller NE; Fogelman AM
    J Lipid Res; 2000 Sep; 41(9):1481-94. PubMed ID: 10974056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.
    Morgantini C; Imaizumi S; Grijalva V; Navab M; Fogelman AM; Reddy ST
    Diabetes; 2010 Dec; 59(12):3223-8. PubMed ID: 20826564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation.
    Cho KH; Kim JR
    Exp Mol Med; 2009 Jun; 41(6):417-28. PubMed ID: 19322022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.